Correlation Between Arrow Financial and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Arrow Financial and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrow Financial and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arrow Financial and Dianthus Therapeutics, you can compare the effects of market volatilities on Arrow Financial and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrow Financial with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrow Financial and Dianthus Therapeutics.

Diversification Opportunities for Arrow Financial and Dianthus Therapeutics

0.22

Correlation Coefficient

Arrow Financial  Dianthus Therapeutics

Modest diversification

The 3 months correlation between Arrow and Dianthus is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Arrow Financial and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Arrow Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrow Financial are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Arrow Financial i.e., Arrow Financial and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Arrow Financial and Dianthus Therapeutics

Given the investment horizon of 90 days Arrow Financial is expected to under-perform the Dianthus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Arrow Financial is 3.22 times less risky than Dianthus Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Dianthus Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  2,318  in Dianthus Therapeutics on December 21, 2024 and sell it today you would lose (274.00) from holding Dianthus Therapeutics or give up 11.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Arrow Financial  vs.  Dianthus Therapeutics

Arrow Financial

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arrow Financial has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Dianthus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Arrow Financial and Dianthus Therapeutics

The main advantage of trading using opposite Arrow Financial and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrow Financial position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Arrow Financial and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.